Add Company
Join Now

Therapixel Revenue and Competitors

License our Company Data API

Nice,

Location

N/A

Total Funding

AI

Industry

Estimated Revenue & Valuation

  • Therapixel's estimated annual revenue is currently $5.6M per year.(i)
  • Therapixel's estimated revenue per employee is $105,660

Employee Data

  • Therapixel has 53 Employees.(i)
  • Therapixel grew their employee count by 13% last year.

Therapixel's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Product Owner Engineer JrReveal Email/Phone
3
CSOReveal Email/Phone
4
Chief Financial OfficerReveal Email/Phone
5
VP Business Operations USReveal Email/Phone
6
Head Software DevelopmentReveal Email/Phone
7
Director Business DevelopmentReveal Email/Phone
8
Chief People and Corporate OfficerReveal Email/Phone
9
Chief Product OfficerReveal Email/Phone
10
Production Manager | SREReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M4N/AN/AN/A
#2
$3.4M20-26%N/AN/A
#3
$27M17526%N/AN/A
#4
$7.7M582%N/AN/A
#5
$175.6M877-6%$91.2MN/A
#6
$1.5M18-5%N/AN/A
#7
$2M20N/AN/AN/A
#8
$0.2M2-33%N/AN/A
#9
$32M20841%N/AN/A
#10
$1.3M16-33%N/AN/A
Add Company

What Is Therapixel?

Therapixel is a leading french software company specialized in artificial intelligence for medical imaging. Our aim is to develop a digital radiologist achieving the performance of best experts. Our AI is dedicated to breast cancer screening. That algorithm won the Digital Mammography DREAM Challenge, the largest Artificial Intelligence challenge ever organized. In its early years, Therapixel developed images visualization software for surgeons to make image access easier and faster from patient consultation to the operating room thanks to gesture control and intuitive user interfaces.

keywords:N/A

N/A

Total Funding

53

Number of Employees

$5.6M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.2M53-22%N/A
#2
$9.4M723%N/A
#3
$13.4M7437%N/A
#4
N/A92217%N/A
#5
$75M9520%N/A